Green Hydrogen Systems receives another order from Liquiline for a new project in Norway
Green Hydrogen Systems receives another order from Liquiline for a new project in Norway
Green Hydrogen Systems, a leading provider of efficient pressurised alkaline electrolysers used in on-site hydrogen production based on renewable electricity, has today signed an agreement with Liquiline for delivering electrolysis equipment for a project in Norway with Dalane Energi as the end customer. Hydrogen Solutions (HYDS) and the Port of Egersund are also closely involved in the project.
The order includes the supply of two GHS HyProvide™ A90 electrolysers with a combined capacity of 0.9 MW for the production of green hydrogen from renewable electricity. Manufactured by Green Hydrogen Systems and operated by Liquiline, the electrolysers will be deployed in a 40 ft container as a complete green hydrogen plant. Green Hydrogen Systems will be responsible for delivering the electrolyser units and will support the project with on-site maintenance and remote monitoring and support as part of a three-year service agreement.
The electrolyser will be part of the EU-funded Horizon 2020 project ROBINSON. Dalane Energi is a partner in the project, which aims to establish a system to combine and integrate local green energy sources such as hydrogen, waste heat, gasification of wood chips, and electricity. The produced hydrogen will be delivered to the ROBINSON project, and in addition sold to external users. The goal is to scale up the production and establish a hydrogen ship bunkering operation in close cooperation with the Port of Egersund.
Liquiline is a Norwegian-based gas technology company and independent provider of services and innovative solutions for transporting and storing liquefied gases. Liquiline has been a Green Hydrogen Systems partner since 2019 and this is its second order from Green Hydrogen Systems.
“We are pleased to be a part of the exciting and ambitious ROBINSON project. We see it as an important step in making green hydrogen commercially available, which is needed to assist the energy transition. We are proud to be a Green Hydrogen Systems partner. Their scalable solutions based on local hydrogen production close to the customers, is specially adapted to countries like Norway with long distances and high distribution costs”, says Knut Førland, Managing Director of Liquiline.
“We at Green Hydrogen Systems are thrilled that Dalane Energi has chosen our efficient electrolysis technology for their exciting project in Norway. We look forward to working on this project together with Dalane Energi and our local partner, Liquiline. Both parties share our vision to pioneer the field of green hydrogen and drive a sustainable global energy transition”, says Green Hydrogen Systems CCO Søren Rydbirk.
When fully operational during Q1 of 2023, the ordered electrolysers have capacity to provide approximately 389 kg green hydrogen per day.
“Dalane Energi had the first establishment of renewable energy supply for public use in south-western Norway in 1905. The company will now be the first establishment of green hydrogen production for public use in the same region. We are very satisfied to be a pioneer making green hydrogen available, and to put Dalane on the Norwegian hydrogen map”, says Idar Sønstabø, Managing Director of Dalane Energi.
About Green Hydrogen Systems
Green Hydrogen Systems is a leading provider of standardised and modular electrolysers for the production of green hydrogen solely based on renewable electricity. With its wide range of possible applications, green hydrogen plays a key role in the ongoing fundamental shift in our energy systems towards a net-zero emission society in 2050. As a result, the demand for green hydrogen is surging, requiring a significant scale-up of electrolysis capacity. Founded in 2007 and building on more than 10 years of technology development, Green Hydrogen Systems today has a commercially proven and cost-competitive electrolysis technology endorsed by leading energy, as well as industrial companies.
Further information: www.greenhydrogen.dk
Founded in 2005 and has long cryogenic experience, mainly from the LNG and LBG business. Liquiline supplies today complete solutions for the production of green hydrogen to Norwegian customers and the international maritime industry. From just a few hundred kW to the multi-MW scale, delivered at the lowest levelised cost of hydrogen available today. Liquiline established HYDS (Hydrogen Solutions) in February 2021 together with SKL (Sunnhordland Kraftlag). HYDS mission is to develop, build and operate plants for local production of green hydrogen, and handle dispensation and bunkering.
Further information: www.liquiline.no
Dalane Energi is a leading regional energy company founded in 1905 and located in Egersund in the southwest part of Norway. Dalane Energi is a group engaged in hydropower production, energy distribution, and energy sales. The company is one of the pioneers within the Norwegian hydropower industry making clean energy possible for over a century. Dalane Energi focuses on energy transition, and the partnership in the EU-funded Horizon 2020 project ROBINSON is part of this strategy.
Further information: www.dalane-energi-konsern.no
For more info please contact:
Investors: Jens Holm Binger, Head of IR, +45 6065 6525, firstname.lastname@example.org
Media: Aleksandra Lozinska, Head of Marketing and Media Relations, +45 4414 0344, email@example.com
Source: Green Hydrogen Systems
Tag: Press release
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Joint Press Release – Kalera and Agrico Announce Effectiveness of Registration Statement, Waiver of Minimum Cash Condition and Extraordinary General Meetings for Proposed Business Combination16.5.2022 08:00:00 CEST | Press release
Extraordinary general meeting of Kalera shareholders (the “Kalera Special Meeting”) and extraordinary general meeting of Agrico shareholders (the “Agrico Special Meeting” and, together with the Kalera Special Meeting, the “Special Meetings”) to approve the proposed business combination of Kalera and Agrico expected to be held on June 27, 2022. Record date for the Kalera Special Meeting is June 6, 2022 (the “Kalera Record Date”); Record date for the Agrico Special Meeting is May 12, 2022 (the “Agrico Record Date” and, together with the Kalera Record Date, the “Record Dates”).Kalera shareholders as of June 6, 2022 voting by proxy should submit their vote by June 22, 2022.Agrico shareholders as of May 12, 2022 voting by proxy should submit their vote by 10:00 a.m., Eastern Time on June 25, 2022.Kalera has waived the minimum cash closing condition. Despite the waiver of the condition, if the minimum cash condition is not satisfied upon the consummation of the business combination, Agrico’s
Inventiva secures a €50 million credit facility from the European Investment Bank16.5.2022 08:00:00 CEST | Press release
This credit facility is intended to support the progress and expansion of Inventiva’s pipelineThe credit facility consists of two tranches of €25 million eachCredit agreement is part of the European Investment Bank’s strategy to support biotech companies developing a high-level of expertise in various therapeutic areas with significant unmet medical needs Daix (France), Long Island City (New York, United States), May 16, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with non-alcoholic steatohepatitis (NASH) and other diseases with significant unmet medical needs, today announced the signing of a €50 million bullet credit facility agreement with the European Investment Bank (“EIB”). The Company plans to use the facility toward its preclinical and clinical pipeline, including to help fund a portion of its Phase III clinical trial of lan
Immunicum AB: Immunicum tillkännager positiva interimsresultat från ADVANCE II-studie i AML-underhållsbehandling16.5.2022 08:00:00 CEST | Pressemelding
Analys av primärstudiens effektmått slutfördes med 7 patienter som visade ett mätbar restsjukdom (MRD)-svar, varav 5 patienter konverterade från MRD+ till MRD- och 2 patienter som visade en avsevärd, minst 10-faldig, minskning av MRD efter behandling med DCP-001Efter en medianuppföljningsperiod på 14,3 månader har medianen för återfallsfri överlevnad (RFS) och total överlevnad (OS) ännu inte uppnåtts.Estimerad RFS vid 6 månader baserad på för närvarande tillgänglig data är 83,7% och estimerad 6-månaders OS är 97,0%Immunicum planerar att presentera fler uppdateringar av överlevnadsdata, inklusive RFS och OS, samt immunövervakningsdata under Q4 2022Företaget håller konferenssamtal och webbsändning i dag kl. 14:00 CET (8:00am ET, 1.00pm GMT) Immunicum AB (“Immunicum” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på behandlingar mot tumörrecidiv och svårbehandlade etablerade tumörer, tillkännagav idag uppdaterade interimsresultat från det pågående ADVANCE II kliniska test som utvärder
Immunicum AB: Immunicum Announces Positive Interim Results from ADVANCE II Study in AML Maintenance Treatment16.5.2022 08:00:00 CEST | Press release
Analysis of primary study endpoint was completed with 7 patients showing a measurable residual disease (MRD) response, of which 5 patients converted from MRD+ to MRD- and 2 patients showed a substantial, at least 10-fold reduction in MRD following treatment with DCP-001After a median follow-up period of 14.3 months, median relapse-free survival (RFS) and overall survival (OS) have not yet been reachedThe estimated 6-month RFS based on the currently available data is 83.7% and the estimated 6-month OS is 97.0%Immunicum plans to present further updates on survival data including RFS and OS, as well as immunomonitoring data in Q4 2022Company to host conference call and webcast today at 14:00 CET (8am ET, 1pm GMT) Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, announced today updated interim results from the ongoing ADVANCE II clinical trial evaluating the company’s lead developmen
Energy partnership agreement between Vantaa Energy and SATO supports the achievement of SATO’s carbon neutrality target16.5.2022 08:00:00 CEST | Press release
SATO Corporation Press release 16 May 2022 at 9:00 am In February 2022, Vantaa Energy and SATO signed an energy partnership agreement that aims to support the achievement of SATO’s carbon neutrality target by 2030. Vantaa Energy leads the way in climate-friendly energy production and enables smooth everyday life for its customers by constantly developing climate-friendly energy services throughout the property lifecycle. SATO is one of Finland’s largest rental housing providers and makes carefree and sustainable rental housing available for its customers. The purpose of the cooperation between Vantaa Energy and SATO is to together promote and develop carbon-neutral energy solutions for the heating and cooling of buildings as well as new innovative ways to reduce energy consumption so that SATO will reach its targets in line with its strategy. Improving the energy efficiency of properties cuts heating costs and is one of the most important actions taken by SATO to curb climate change an